SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations
CHINO HILLS, CA / ACCESS Newswire / June 11, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and wellness solutions, proudly announces the appointment of Dr. Larissa Karnaoukhova, Ph.D, MBA, as Vice President of Operations. With extensive experience in site operations management, sales, and business development within highly regulated industries, Larissa will play a pivotal role in enhancing operational efficiency and driving strategic initiatives at SOHM Inc.
David Aguilar, COO of SOHM Inc., warmly welcomes Larissa to the leadership team. 'Larissa brings a wealth of expertise and a proven track record in managing complex operations and achieving key performance indicators. Her dynamic leadership style and commitment to excellence align perfectly with our mission to deliver high-quality products and services to our clients,' Aguilar stated.
Larissa has held prominent roles, including Senior Director of Operations at Universal Sequencing Technology, where she successfully oversaw manufacturing, quality control, and supply chain management. Her background also includes significant achievements in project management, customer engagement, and quality assurance across various organizations, including AutoGenomics and LumiraDx, Nucleus Biologics and Invitrogen/Life Technologies. At SOHM, she will lead in further development of QA/QC, FDA audits, process validations, SOPs and other quality initiatives.
'I am excited to join SOHM Inc. and collaborate with a talented team dedicated to innovation and quality,' said Larissa. 'Together, we will strive to enhance our operational capabilities, improve customer satisfaction, and drive the company's growth in the health sciences sector.'
Her academic credentials, including an MBA and a Ph.D. in Molecular Biology, complement her extensive professional background, providing a strong foundation for her new role. With her strategic mindset and technical expertise, Larissa is set to lead SOHM's operations into a new era of efficiency and quality.
About SOHM, Inc.:
SOHM is a biopharmaceutical company dedicated to developing and commercializing gene editing technologies for research, synthetic biology, and therapeutic applications. With a focus on precision medicine, SOHM aims to revolutionize the treatment of genetic diseases by providing safe, efficient, and targeted solutions for gene editing. Through strategic collaborations and groundbreaking research, SOHM is at the forefront of advancing the field of gene therapy. SOHM strives to transform the landscape of genome editing and improve the quality of life through scientific discovery.
For further information regarding this announcement or to explore potential collaborations, please contact:
SOHM, Inc.:
Name: Baron Night, CEO/Dr. David Aguilar, COO
Email: [email protected]
Phone: (714) 522-6700
Safe Harbor Statement:
This news release contains 'forward-looking statements,' which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development-stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year and our quarterly reports uploaded from time to time on OTCMarkets.com.
SOURCE: SOHM, Inc.
press release
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Wall Street Is Bullish on AMD's s AI Push—Here's Why
Advanced Micro Devices, Inc. (NASDAQ:) is one of the . On June 16, Piper Sandler analyst Harsh Kumar raised the price target on the stock to $140.00 (from $125.00) while maintaining a 'Overweight' rating. The firm cited growing optimism in the company's graphics processing unit (GPU) segment and confidence in its ability to continue driving strong results behind the price target raise. Piper Sandler is optimistic about AMD's latest product launches, particularly the new Helios rack system. It believes the system could boost growth in AMD's Instinct AI accelerator business. The firm made these comments shortly after the company revealed its new MI350 AI chips and previewed the upcoming MI400 series. Kumar also highlighted AMD's biggest segment, its client business, which is starting to show signs of improvement. The company's 'pull-ins' reflect how customers are ordering earlier than expected. Kumar further added that AMD's GPU business could revive by the fourth quarter of Fiscal 2025 once China-related issues resolve. To conclude, investors are confident about AMD's strategy and upcoming AI products. The firm's revised forecast suggests that the company can sustain ground in the competitive semiconductor market. Advanced Micro Devices, Inc. (NASDAQ:AMD) develops and sells semiconductors, processors, and GPUs for data centers, gaming, AI, and embedded applications. While we acknowledge the potential of AMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
27 minutes ago
- Yahoo
Do Options Traders Know Something About Entegris Stock We Don't?
Investors in Entegris, Inc. ENTG need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $55.00 Call had some of the highest implied volatility of all equity options today. Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy. Clearly, options traders are pricing in a big move for Entegris shares, but what is the fundamental picture for the company? Currently, Entegris is a Zacks Rank #5 (Strong Sell) in the Electronics - Manufacturing Machinery industry that ranks in the Bottom 6% of our Zacks Industry Rank. Over the last 60 days, no analysts have increased their earnings estimates for the current quarter, while two analysts have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from 72 cents per share to 64 cents in that period. Given the way analysts feel about Entegris right now, this huge implied volatility could mean there's a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected. Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk. Click to see the trades now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Entegris, Inc. (ENTG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
Amazon (AMZN) and Roku Partner to Revolutionize Connected TV Advertising
Inc. (NASDAQ:AMZN) is one of the 11 must-buy AI stocks analysts are betting on. On June 16, the company's advertising unit, Amazon Ads, entered a strategic partnership with Roku, Inc. (NASDAQ:ROKU). The two are joining forces to create the largest authenticated footprint in connected TV. Amazon Ads and Roku are to enable advertisers to reach an estimated 80 million US households through the Amazon demand-side platform. The partnership aims to enable unprecedented precision at scale by allowing markets to access logged-in users across all apps and devices in a way that was not possible before. Early tests following the integration have already shown a 40% increase in unique reach and a 30% reduction in over-frequency. Consequently, advertisers delivered three times more value from their campaigns. Advertisers are set to benefit from better performance, planning, optimization, and measurement due to the extraordinary scale. Addressability across popular streaming apps, such as The Roku Channel, Prime Video, and other top CTV streaming services on Roku and Fire TV operating systems, has also received a boost owing to the exclusive alliance between two industry leaders in CTV. Inc. (NASDAQ:AMZN) started as an online bookselling company. It has since morphed into an internet-based business enterprise that provides cloud computing, digital streaming and AI services, and an e-commerce platform. The platform operates in more than 20 countries worldwide. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best Healthcare Stocks to Buy Now and 10 Stocks Analysts Are Upgrading Today. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
